Munukka et al., 2012 - Google Patents
Women with and without metabolic disorder differ in their gut microbiota compositionMunukka et al., 2012
View PDF- Document ID
- 5338878686941726162
- Author
- Munukka E
- Wiklund P
- Pekkala S
- Völgyi E
- Xu L
- Cheng S
- Lyytikäinen A
- Marjomäki V
- Alen M
- Vaahtovuo J
- Keinänen‐Kiukaanniemi S
- Cheng S
- Publication year
- Publication venue
- Obesity
External Links
Snippet
The aim of this study was to investigate whether overweight/obese women in metabolic disorder group (MDG, n= 27) differ in their gut microbiota composition from overweight/obese women in non‐metabolic disorder group (NMDG, n= 47) and normal …
- 241000736262 Microbiota 0 title abstract description 40
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/5308—Immunoassay; Biospecific binding assay for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Munukka et al. | Women with and without metabolic disorder differ in their gut microbiota composition | |
| Samaras et al. | Genetic and environmental influences on total-body and central abdominal fat: the effect of physical activity in female twins | |
| Koliada et al. | Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population | |
| Jung et al. | Chronic repression of mTOR complex 2 induces changes in the gut microbiota of diet-induced obese mice | |
| Amar et al. | Energy intake is associated with endotoxemia in apparently healthy men | |
| Van Oeffelen et al. | Serum micronutrient concentrations and childhood asthma: the PIAMA birth cohort study | |
| Agüero-Torres et al. | Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study | |
| Wang et al. | Measures of adiposity and risk of stroke in China: a result from the Kailuan study | |
| Souza et al. | Factors associated with sarcopenia in patients with colorectal cancer | |
| Al-Daghri et al. | Gender-dependent associations between socioeconomic status and metabolic syndrome: a cross-sectional study in the adult Saudi population | |
| Bennet et al. | High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighbourhood-a population based study | |
| Fjaellegaard et al. | Well-being and depression in individuals with subclinical hypothyroidism and thyroid autoimmunity—a general population study | |
| Hod et al. | Assessment of high‐sensitivity CRP as a marker of micro‐inflammation in irritable bowel syndrome | |
| Sodhi et al. | Prevalence of gallstone disease in patients with type 2 diabetes and the risk factors in North Indian population: a case control study | |
| Shiroma et al. | Physical activity and weight gain prevention in older men | |
| Rutters et al. | Stressful life events and incident metabolic syndrome: the Hoorn study | |
| Hulman et al. | Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk | |
| Lamers et al. | Repeated prolonged moderate-intensity walking exercise does not appear to have harmful effects on inflammatory markers in patients with inflammatory bowel disease | |
| Martin et al. | Neighborhood disadvantage across the transition from adolescence to adulthood and risk of metabolic syndrome | |
| Chaput et al. | Workplace standing time and the incidence of obesity and type 2 diabetes: a longitudinal study in adults | |
| Liao et al. | Associations of metabolic/obesity phenotypes with insulin resistance and C-reactive protein: results from the cntr study | |
| Romon et al. | Postprandial leptin response to carbohydrate and fat meals in obese women | |
| Merten | Weight status continuity and change from adolescence to young adulthood: examining disease and health risk conditions | |
| Blanco-Rojo et al. | Interaction of an S100A9 gene variant with saturated fat and carbohydrates to modulate insulin resistance in 3 populations of different ancestries | |
| Tucker | Insulin resistance and biological aging: the role of body mass, waist circumference, and inflammation |